Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Angiography | 43 | 2020 | 262 | 5.610 |
Why?
|
Cerebrovascular Circulation | 20 | 2022 | 212 | 4.060 |
Why?
|
Magnetic Resonance Imaging | 45 | 2023 | 3362 | 3.480 |
Why?
|
Contrast Media | 42 | 2021 | 1078 | 3.270 |
Why?
|
Image Interpretation, Computer-Assisted | 20 | 2019 | 663 | 2.450 |
Why?
|
Gadolinium DTPA | 16 | 2013 | 261 | 1.850 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2022 | 35 | 1.790 |
Why?
|
Collateral Circulation | 4 | 2020 | 35 | 1.610 |
Why?
|
Stroke | 12 | 2023 | 965 | 1.570 |
Why?
|
Image Enhancement | 17 | 2016 | 563 | 1.350 |
Why?
|
Blood Flow Velocity | 12 | 2016 | 197 | 1.280 |
Why?
|
Perfusion Imaging | 4 | 2021 | 50 | 1.260 |
Why?
|
Image Processing, Computer-Assisted | 21 | 2019 | 1204 | 1.190 |
Why?
|
Artifacts | 7 | 2017 | 244 | 1.130 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 7 | 2023 | 223 | 1.120 |
Why?
|
Cerebrovascular Disorders | 4 | 2013 | 143 | 1.090 |
Why?
|
Angiography, Digital Subtraction | 10 | 2016 | 92 | 1.060 |
Why?
|
Brain | 12 | 2022 | 2216 | 1.030 |
Why?
|
Echo-Planar Imaging | 3 | 2010 | 52 | 1.030 |
Why?
|
Brain Ischemia | 5 | 2022 | 398 | 0.990 |
Why?
|
Femoral Artery | 9 | 2017 | 81 | 0.940 |
Why?
|
Brain Neoplasms | 6 | 2021 | 763 | 0.940 |
Why?
|
Dogs | 7 | 2022 | 685 | 0.920 |
Why?
|
Imaging, Three-Dimensional | 16 | 2017 | 579 | 0.890 |
Why?
|
Intracranial Arteriovenous Malformations | 4 | 2014 | 104 | 0.880 |
Why?
|
Hand | 1 | 2023 | 130 | 0.870 |
Why?
|
Central Nervous System Vascular Malformations | 3 | 2012 | 32 | 0.850 |
Why?
|
Blood Volume | 3 | 2013 | 51 | 0.840 |
Why?
|
Carboxyhemoglobin | 1 | 2021 | 16 | 0.840 |
Why?
|
Hydralazine | 2 | 2022 | 20 | 0.820 |
Why?
|
Norepinephrine | 2 | 2022 | 167 | 0.790 |
Why?
|
Peripheral Arterial Disease | 7 | 2017 | 88 | 0.780 |
Why?
|
Leg | 9 | 2023 | 137 | 0.760 |
Why?
|
Algorithms | 11 | 2017 | 1830 | 0.740 |
Why?
|
Humans | 98 | 2024 | 86643 | 0.740 |
Why?
|
Psychomotor Performance | 1 | 2023 | 492 | 0.740 |
Why?
|
Cerebral Arteries | 3 | 2011 | 74 | 0.730 |
Why?
|
Gadolinium | 4 | 2014 | 103 | 0.720 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2020 | 294 | 0.720 |
Why?
|
Capillary Permeability | 2 | 2021 | 130 | 0.710 |
Why?
|
Cerebral Infarction | 2 | 2017 | 71 | 0.710 |
Why?
|
Female | 66 | 2024 | 44532 | 0.690 |
Why?
|
Isotopes | 1 | 2019 | 26 | 0.690 |
Why?
|
Male | 65 | 2024 | 40965 | 0.680 |
Why?
|
Migraine Disorders | 1 | 2019 | 40 | 0.680 |
Why?
|
Oxygen Radioisotopes | 2 | 2013 | 4 | 0.680 |
Why?
|
Sensitivity and Specificity | 19 | 2021 | 1991 | 0.660 |
Why?
|
Adult | 45 | 2023 | 25648 | 0.660 |
Why?
|
Intracranial Aneurysm | 2 | 2017 | 158 | 0.650 |
Why?
|
Reproducibility of Results | 20 | 2019 | 2705 | 0.650 |
Why?
|
Organometallic Compounds | 4 | 2014 | 132 | 0.650 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 894 | 0.640 |
Why?
|
Muscle, Skeletal | 4 | 2023 | 449 | 0.620 |
Why?
|
Hemodynamics | 4 | 2015 | 710 | 0.610 |
Why?
|
Cerebral Angiography | 2 | 2012 | 196 | 0.600 |
Why?
|
Spinal Cord | 2 | 2011 | 249 | 0.600 |
Why?
|
Pia Mater | 1 | 2016 | 5 | 0.590 |
Why?
|
Hemangioma, Cavernous | 3 | 2021 | 69 | 0.570 |
Why?
|
Middle Aged | 43 | 2021 | 25028 | 0.560 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 4 | 2017 | 54 | 0.560 |
Why?
|
Myocardium | 3 | 2014 | 529 | 0.560 |
Why?
|
Blood Volume Determination | 2 | 2013 | 14 | 0.550 |
Why?
|
Pulmonary Circulation | 1 | 2015 | 86 | 0.530 |
Why?
|
Plaque, Atherosclerotic | 5 | 2017 | 54 | 0.530 |
Why?
|
Multiple Sclerosis | 3 | 2023 | 262 | 0.520 |
Why?
|
Hemorrhage | 5 | 2023 | 268 | 0.510 |
Why?
|
Aged | 36 | 2021 | 18415 | 0.510 |
Why?
|
Cerebral Hemorrhage | 4 | 2023 | 325 | 0.490 |
Why?
|
Body Water | 1 | 2013 | 35 | 0.480 |
Why?
|
Movement | 4 | 2024 | 299 | 0.480 |
Why?
|
Models, Theoretical | 1 | 2016 | 482 | 0.470 |
Why?
|
Moyamoya Disease | 1 | 2013 | 14 | 0.460 |
Why?
|
Glioblastoma | 2 | 2019 | 255 | 0.460 |
Why?
|
Feasibility Studies | 9 | 2019 | 751 | 0.450 |
Why?
|
Angiography | 2 | 2011 | 208 | 0.440 |
Why?
|
Biomarkers | 9 | 2023 | 1718 | 0.440 |
Why?
|
Renal Circulation | 1 | 2012 | 61 | 0.420 |
Why?
|
Hypertension, Pulmonary | 2 | 2015 | 346 | 0.420 |
Why?
|
Pilot Projects | 5 | 2022 | 839 | 0.410 |
Why?
|
Disease Models, Animal | 7 | 2021 | 2232 | 0.410 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 329 | 0.380 |
Why?
|
Brain Mapping | 1 | 2014 | 548 | 0.380 |
Why?
|
Ankle Brachial Index | 7 | 2017 | 27 | 0.370 |
Why?
|
Cognitive Dysfunction | 3 | 2017 | 132 | 0.360 |
Why?
|
Computer Simulation | 7 | 2017 | 1078 | 0.350 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2017 | 159 | 0.350 |
Why?
|
White Matter | 4 | 2018 | 80 | 0.350 |
Why?
|
Water | 2 | 2013 | 277 | 0.350 |
Why?
|
Carotid Artery Diseases | 3 | 2019 | 97 | 0.350 |
Why?
|
Vascular Malformations | 1 | 2009 | 19 | 0.340 |
Why?
|
Phantoms, Imaging | 5 | 2019 | 429 | 0.340 |
Why?
|
Animals | 19 | 2024 | 26582 | 0.330 |
Why?
|
Kidney | 2 | 2012 | 1241 | 0.330 |
Why?
|
Gray Matter | 2 | 2018 | 33 | 0.310 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 353 | 0.310 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 311 | 0.310 |
Why?
|
Ischemia | 2 | 2021 | 243 | 0.310 |
Why?
|
Brain Diseases | 1 | 2008 | 180 | 0.300 |
Why?
|
Forearm | 1 | 2007 | 32 | 0.300 |
Why?
|
Carotid Arteries | 5 | 2007 | 127 | 0.290 |
Why?
|
Brain Edema | 2 | 2018 | 50 | 0.290 |
Why?
|
Permeability | 4 | 2021 | 137 | 0.290 |
Why?
|
Renal Artery Obstruction | 4 | 2007 | 39 | 0.290 |
Why?
|
Upper Extremity | 2 | 2023 | 52 | 0.270 |
Why?
|
Walking | 4 | 2014 | 87 | 0.260 |
Why?
|
Wrist | 1 | 2004 | 22 | 0.260 |
Why?
|
Artificial Intelligence | 1 | 2007 | 298 | 0.250 |
Why?
|
Time Factors | 13 | 2018 | 5210 | 0.250 |
Why?
|
Aged, 80 and over | 10 | 2017 | 6509 | 0.240 |
Why?
|
Heart | 3 | 2017 | 539 | 0.240 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 1376 | 0.240 |
Why?
|
Prospective Studies | 9 | 2023 | 4213 | 0.240 |
Why?
|
Bicycling | 1 | 2023 | 12 | 0.230 |
Why?
|
Myalgia | 1 | 2023 | 7 | 0.230 |
Why?
|
Motor Skills | 1 | 2024 | 71 | 0.230 |
Why?
|
Motor Neurons | 1 | 2004 | 162 | 0.230 |
Why?
|
Vasodilator Agents | 2 | 2022 | 152 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 2601 | 0.230 |
Why?
|
Oxygen | 2 | 2021 | 726 | 0.230 |
Why?
|
Cattle | 2 | 2021 | 376 | 0.230 |
Why?
|
Intracranial Arteriosclerosis | 2 | 2017 | 49 | 0.230 |
Why?
|
Retrospective Studies | 14 | 2023 | 8489 | 0.220 |
Why?
|
Neural Pathways | 1 | 2004 | 308 | 0.220 |
Why?
|
Aortic Diseases | 3 | 2007 | 100 | 0.220 |
Why?
|
Tomography, Emission-Computed | 1 | 2002 | 103 | 0.220 |
Why?
|
Blood Vessel Prosthesis | 3 | 2010 | 228 | 0.210 |
Why?
|
Dopamine | 1 | 2024 | 275 | 0.210 |
Why?
|
Quality of Life | 3 | 2023 | 1585 | 0.210 |
Why?
|
Deception | 1 | 2022 | 20 | 0.210 |
Why?
|
Principal Component Analysis | 1 | 2002 | 155 | 0.210 |
Why?
|
Cerebral Cortex | 2 | 2016 | 584 | 0.200 |
Why?
|
Predictive Value of Tests | 8 | 2017 | 1673 | 0.200 |
Why?
|
Lipids | 3 | 2017 | 269 | 0.190 |
Why?
|
Treatment Outcome | 7 | 2023 | 7993 | 0.190 |
Why?
|
Hepatic Encephalopathy | 2 | 2018 | 40 | 0.190 |
Why?
|
Brain Stem | 1 | 2021 | 165 | 0.190 |
Why?
|
Peripheral Vascular Diseases | 3 | 2009 | 62 | 0.190 |
Why?
|
Reference Values | 4 | 2013 | 674 | 0.190 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 53 | 0.190 |
Why?
|
Software | 3 | 2017 | 654 | 0.180 |
Why?
|
Healthy Aging | 1 | 2019 | 8 | 0.180 |
Why?
|
Models, Cardiovascular | 3 | 2016 | 98 | 0.180 |
Why?
|
Arteries | 1 | 2000 | 176 | 0.180 |
Why?
|
Vascular Calcification | 2 | 2017 | 39 | 0.180 |
Why?
|
Polyethylene Glycols | 1 | 2021 | 363 | 0.170 |
Why?
|
Aneurysm | 2 | 2017 | 58 | 0.170 |
Why?
|
Middle Cerebral Artery | 1 | 2019 | 21 | 0.170 |
Why?
|
Ki-67 Antigen | 1 | 2019 | 64 | 0.170 |
Why?
|
Transcriptome | 2 | 2021 | 580 | 0.170 |
Why?
|
Natalizumab | 1 | 2018 | 21 | 0.170 |
Why?
|
Hypercapnia | 1 | 2019 | 43 | 0.170 |
Why?
|
Cohort Studies | 7 | 2021 | 2767 | 0.170 |
Why?
|
Microspheres | 1 | 2019 | 101 | 0.170 |
Why?
|
Muscle Contraction | 3 | 2023 | 283 | 0.170 |
Why?
|
Brain Infarction | 1 | 2018 | 22 | 0.160 |
Why?
|
Central Nervous System Neoplasms | 1 | 2019 | 81 | 0.160 |
Why?
|
Severity of Illness Index | 7 | 2018 | 1801 | 0.160 |
Why?
|
Heart Ventricles | 2 | 2016 | 760 | 0.160 |
Why?
|
Dependent Ambulation | 1 | 2017 | 3 | 0.160 |
Why?
|
Aorta, Thoracic | 3 | 2007 | 165 | 0.160 |
Why?
|
Young Adult | 5 | 2016 | 5976 | 0.160 |
Why?
|
Mobility Limitation | 1 | 2017 | 19 | 0.160 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2017 | 16 | 0.150 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2017 | 8 | 0.150 |
Why?
|
Perfusion | 3 | 2022 | 203 | 0.150 |
Why?
|
Nervous System Diseases | 1 | 2018 | 151 | 0.150 |
Why?
|
Tissue Distribution | 2 | 2014 | 290 | 0.140 |
Why?
|
Patient Outcome Assessment | 1 | 2017 | 84 | 0.140 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 381 | 0.140 |
Why?
|
Sample Size | 1 | 2017 | 130 | 0.140 |
Why?
|
Breath Holding | 1 | 2016 | 22 | 0.140 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2016 | 47 | 0.140 |
Why?
|
Swine | 8 | 2016 | 555 | 0.140 |
Why?
|
Saline Solution, Hypertonic | 1 | 2016 | 24 | 0.140 |
Why?
|
Coronary Circulation | 1 | 2016 | 130 | 0.140 |
Why?
|
Subtraction Technique | 1 | 2016 | 133 | 0.140 |
Why?
|
Kinetics | 2 | 2017 | 1513 | 0.130 |
Why?
|
Cognition Disorders | 1 | 2017 | 236 | 0.130 |
Why?
|
Ovarian Diseases | 1 | 2014 | 32 | 0.130 |
Why?
|
Chicago | 5 | 2019 | 1379 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 1 | 2014 | 59 | 0.120 |
Why?
|
Multivariate Analysis | 1 | 2017 | 999 | 0.120 |
Why?
|
Embolization, Therapeutic | 2 | 2014 | 238 | 0.120 |
Why?
|
Infertility, Female | 1 | 2014 | 93 | 0.120 |
Why?
|
Metabolic Clearance Rate | 1 | 2013 | 121 | 0.120 |
Why?
|
Thalamus | 3 | 2022 | 132 | 0.120 |
Why?
|
Electromyography | 2 | 2023 | 183 | 0.120 |
Why?
|
Tomography, Optical Coherence | 1 | 2014 | 130 | 0.120 |
Why?
|
Albumins | 1 | 2014 | 133 | 0.120 |
Why?
|
Ovary | 1 | 2014 | 258 | 0.110 |
Why?
|
Molecular Imaging | 1 | 2014 | 64 | 0.110 |
Why?
|
Models, Statistical | 1 | 2017 | 574 | 0.110 |
Why?
|
Nerve Net | 1 | 2017 | 366 | 0.110 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 916 | 0.110 |
Why?
|
Arteriovenous Fistula | 1 | 2013 | 52 | 0.110 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 859 | 0.110 |
Why?
|
Glomerular Filtration Rate | 3 | 2011 | 384 | 0.110 |
Why?
|
Magnetic Fields | 1 | 2012 | 11 | 0.110 |
Why?
|
Statistics as Topic | 1 | 2013 | 238 | 0.100 |
Why?
|
Vascular Surgical Procedures | 2 | 2016 | 148 | 0.100 |
Why?
|
Radiopharmaceuticals | 1 | 2013 | 180 | 0.100 |
Why?
|
Longitudinal Studies | 3 | 2021 | 1019 | 0.100 |
Why?
|
Elastomers | 1 | 2010 | 2 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2011 | 141 | 0.090 |
Why?
|
Creatinine | 1 | 2011 | 338 | 0.090 |
Why?
|
Citrates | 1 | 2010 | 28 | 0.090 |
Why?
|
Comorbidity | 4 | 2016 | 943 | 0.090 |
Why?
|
Pulmonary Veins | 1 | 2011 | 72 | 0.090 |
Why?
|
Area Under Curve | 1 | 2010 | 334 | 0.090 |
Why?
|
Regional Blood Flow | 3 | 2017 | 197 | 0.090 |
Why?
|
Angioplasty, Balloon | 2 | 2007 | 95 | 0.090 |
Why?
|
Bayes Theorem | 2 | 2021 | 361 | 0.090 |
Why?
|
Cicatrix | 1 | 2009 | 63 | 0.090 |
Why?
|
Monitoring, Intraoperative | 1 | 2009 | 109 | 0.090 |
Why?
|
Stereotaxic Techniques | 1 | 2009 | 69 | 0.090 |
Why?
|
Bevacizumab | 1 | 2010 | 281 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 2011 | 306 | 0.080 |
Why?
|
Machine Learning | 2 | 2021 | 232 | 0.080 |
Why?
|
Polymers | 1 | 2010 | 202 | 0.080 |
Why?
|
Stents | 2 | 2009 | 377 | 0.080 |
Why?
|
Calibration | 2 | 2006 | 99 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2010 | 193 | 0.080 |
Why?
|
Risk Factors | 5 | 2019 | 5417 | 0.080 |
Why?
|
Random Allocation | 2 | 2014 | 332 | 0.080 |
Why?
|
Arteriosclerosis | 2 | 2006 | 113 | 0.080 |
Why?
|
Subclavian Steal Syndrome | 1 | 2007 | 2 | 0.080 |
Why?
|
Polytetrafluoroethylene | 1 | 2007 | 74 | 0.080 |
Why?
|
Carotid Artery, External | 1 | 2007 | 8 | 0.080 |
Why?
|
Ferrosoferric Oxide | 1 | 2007 | 18 | 0.080 |
Why?
|
Tunica Intima | 1 | 2007 | 59 | 0.080 |
Why?
|
Magnetite Nanoparticles | 1 | 2007 | 27 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2010 | 244 | 0.070 |
Why?
|
Dextrans | 1 | 2007 | 77 | 0.070 |
Why?
|
ROC Curve | 3 | 2019 | 752 | 0.070 |
Why?
|
Oxides | 1 | 2007 | 43 | 0.070 |
Why?
|
Organ Size | 2 | 2018 | 364 | 0.070 |
Why?
|
Magnetics | 1 | 2006 | 41 | 0.070 |
Why?
|
Lower Extremity | 2 | 2023 | 84 | 0.070 |
Why?
|
Iron | 1 | 2007 | 164 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 509 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2006 | 99 | 0.070 |
Why?
|
Necrosis | 2 | 2017 | 204 | 0.070 |
Why?
|
Adolescent | 4 | 2014 | 8981 | 0.070 |
Why?
|
Disease Progression | 1 | 2010 | 1531 | 0.070 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2005 | 14 | 0.070 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2006 | 71 | 0.070 |
Why?
|
Radial Nerve | 1 | 2004 | 2 | 0.060 |
Why?
|
H-Reflex | 1 | 2004 | 8 | 0.060 |
Why?
|
Muscle Spindles | 1 | 2004 | 5 | 0.060 |
Why?
|
Spinal Nerve Roots | 1 | 2004 | 17 | 0.060 |
Why?
|
Median Nerve | 1 | 2004 | 11 | 0.060 |
Why?
|
Smoking | 2 | 2014 | 609 | 0.060 |
Why?
|
Fibrosis | 2 | 2016 | 203 | 0.060 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2010 | 930 | 0.060 |
Why?
|
Afferent Pathways | 1 | 2004 | 77 | 0.060 |
Why?
|
Sex Factors | 1 | 2007 | 1054 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2021 | 1805 | 0.060 |
Why?
|
Interneurons | 1 | 2004 | 93 | 0.060 |
Why?
|
Neural Inhibition | 1 | 2004 | 97 | 0.060 |
Why?
|
Logistic Models | 2 | 2021 | 1186 | 0.060 |
Why?
|
Levodopa | 1 | 2024 | 36 | 0.060 |
Why?
|
Electric Stimulation | 1 | 2004 | 347 | 0.060 |
Why?
|
Quadriceps Muscle | 1 | 2023 | 5 | 0.060 |
Why?
|
Temporal Lobe | 2 | 2016 | 172 | 0.060 |
Why?
|
Heel | 1 | 2023 | 4 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2006 | 355 | 0.060 |
Why?
|
Age Factors | 1 | 2007 | 1851 | 0.060 |
Why?
|
Limbic System | 1 | 2022 | 23 | 0.060 |
Why?
|
Biophysical Phenomena | 1 | 2002 | 120 | 0.050 |
Why?
|
Biophysics | 1 | 2002 | 152 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2003 | 201 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2002 | 153 | 0.050 |
Why?
|
Arterial Occlusive Diseases | 1 | 2002 | 107 | 0.050 |
Why?
|
Observer Variation | 3 | 2015 | 602 | 0.050 |
Why?
|
Linear Models | 3 | 2009 | 421 | 0.050 |
Why?
|
Aorta, Abdominal | 1 | 2001 | 60 | 0.050 |
Why?
|
Biomechanical Phenomena | 1 | 2023 | 457 | 0.050 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 364 | 0.050 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 213 | 0.050 |
Why?
|
Injections, Intravenous | 1 | 2001 | 244 | 0.050 |
Why?
|
Exercise Test | 2 | 2013 | 164 | 0.050 |
Why?
|
Child | 2 | 2003 | 6927 | 0.050 |
Why?
|
Learning | 1 | 2024 | 280 | 0.050 |
Why?
|
Neuroimaging | 1 | 2021 | 113 | 0.050 |
Why?
|
Plasma | 1 | 2020 | 50 | 0.050 |
Why?
|
Vitamin D | 1 | 2023 | 261 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2021 | 154 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2013 | 912 | 0.050 |
Why?
|
Exercise | 1 | 2023 | 315 | 0.040 |
Why?
|
Prevalence | 2 | 2014 | 1239 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2018 | 56 | 0.040 |
Why?
|
Atrophy | 1 | 2018 | 117 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 318 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 407 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 2018 | 181 | 0.040 |
Why?
|
Clinical Deterioration | 1 | 2018 | 19 | 0.040 |
Why?
|
Tumor Burden | 1 | 2019 | 289 | 0.040 |
Why?
|
Walk Test | 1 | 2017 | 21 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2017 | 70 | 0.040 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2016 | 33 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2017 | 136 | 0.040 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2017 | 64 | 0.040 |
Why?
|
Infant | 1 | 2003 | 3046 | 0.040 |
Why?
|
Blood Vessels | 2 | 2010 | 94 | 0.040 |
Why?
|
Limbic Lobe | 1 | 2016 | 1 | 0.040 |
Why?
|
Genotype | 1 | 2021 | 1851 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2016 | 45 | 0.030 |
Why?
|
Putamen | 1 | 2016 | 13 | 0.030 |
Why?
|
Child, Preschool | 1 | 2003 | 3612 | 0.030 |
Why?
|
Aging | 1 | 2020 | 691 | 0.030 |
Why?
|
Frontal Lobe | 1 | 2016 | 130 | 0.030 |
Why?
|
Electrocardiography | 2 | 2007 | 478 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2016 | 117 | 0.030 |
Why?
|
Oscillometry | 1 | 2014 | 25 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 860 | 0.030 |
Why?
|
Critical Illness | 1 | 2016 | 294 | 0.030 |
Why?
|
Shear Strength | 1 | 2013 | 19 | 0.030 |
Why?
|
Prognosis | 1 | 2021 | 3679 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2013 | 248 | 0.030 |
Why?
|
Intermittent Claudication | 1 | 2012 | 20 | 0.030 |
Why?
|
Computer Systems | 1 | 2012 | 79 | 0.030 |
Why?
|
Risk Assessment | 1 | 2019 | 2261 | 0.030 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2011 | 9 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2014 | 213 | 0.030 |
Why?
|
Meglumine | 1 | 2011 | 39 | 0.030 |
Why?
|
Actigraphy | 1 | 2011 | 51 | 0.020 |
Why?
|
Familial Primary Pulmonary Hypertension | 1 | 2011 | 60 | 0.020 |
Why?
|
Lipoproteins | 1 | 2011 | 135 | 0.020 |
Why?
|
Sus scrofa | 1 | 2010 | 45 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2010 | 135 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2017 | 3640 | 0.020 |
Why?
|
Angioplasty | 1 | 2009 | 70 | 0.020 |
Why?
|
Monocytes | 1 | 2010 | 214 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 1621 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 435 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2007 | 40 | 0.020 |
Why?
|
Ultrasonography | 1 | 2010 | 695 | 0.020 |
Why?
|
Hyperplasia | 1 | 2007 | 148 | 0.020 |
Why?
|
Renal Artery | 1 | 2007 | 64 | 0.020 |
Why?
|
Thrombosis | 1 | 2010 | 296 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2007 | 119 | 0.020 |
Why?
|
Macrophages | 1 | 2010 | 554 | 0.020 |
Why?
|
Models, Biological | 1 | 2014 | 1749 | 0.020 |
Why?
|
Iohexol | 1 | 2006 | 26 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 307 | 0.020 |
Why?
|
Swine, Miniature | 1 | 2006 | 51 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 376 | 0.020 |
Why?
|
Blood | 1 | 2006 | 69 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2005 | 33 | 0.020 |
Why?
|
Thigh | 1 | 2004 | 38 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2005 | 58 | 0.020 |
Why?
|
Inflammation | 1 | 2010 | 920 | 0.020 |
Why?
|
Abdomen | 1 | 2004 | 122 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2011 | 2501 | 0.010 |
Why?
|
Fourier Analysis | 1 | 2002 | 125 | 0.010 |
Why?
|
Injections | 1 | 2001 | 109 | 0.010 |
Why?
|
Models, Animal | 1 | 2002 | 263 | 0.010 |
Why?
|
Mice | 1 | 2014 | 11352 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 1999 | 112 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 1999 | 462 | 0.010 |
Why?
|